Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease

<p>Multiple myeloma is a fatal haematological malignancy, in which the majority of patients either present with or develop a destructive and debilitating osteolytic bone disease. The bone disease is characterised by an increase in osteoclastogenesis and by osteoblast suppression. Current trea...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur: Leng, H
Awduron Eraill: Simon, K
Fformat: Traethawd Ymchwil
Iaith:English
Cyhoeddwyd: 2019
Pynciau:

Eitemau Tebyg